Pharmaceuticals Global Industry Almanac 2017

Date: May 31, 2017
Pages: 505
Price:
US$ 2,995.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P58039C4F4CEN
Leaflet:

Download PDF Leaflet

Pharmaceuticals Global Industry Almanac 2017
Pharmaceuticals Global Industry Almanac 2017

SUMMARY

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

SYNOPSIS

Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

KEY HIGHLIGHTS
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.
  • The global pharmaceuticals market had total revenues of $946.1bn in 2016, representing a compound annual growth rate (CAGR) of 6.1% between 2012 and 2016.
  • The US, Japan and China are the largest global pharmaceutical markets followed by the four biggest European markets: France, Germany, the UK, and Italy. Amongst that number it is China that is producing the strongest growth every year, whilst the European states have been stifled due to current healthcare spending cultures in the region.
  • The patent cliff has caused revenue losses for many companies. The sales of Pfizer, Novartis and Merck & Co. fell when they lost their patents for Lipitor, Diovan and Singulair, respectively. AstraZeneca has been particularly affected by the patent cliff.
SCOPE
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts
REASONS TO BUY
  • What was the size of the global pharmaceuticals market by value in 2016?
  • What will be the size of the global pharmaceuticals market in 2021?
  • What factors are affecting the strength of competition in the global pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the global pharmaceuticals market?
EXECUTIVE SUMMARY
Market value
Market value forecast
Geography segmentation
Market share
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Global Pharmaceuticals
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Asia-Pacific
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Europe
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in France
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Germany
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Australia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Brazil
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Canada
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in India
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Indonesia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Italy
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Japan
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Mexico
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The Netherlands
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in North America
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Russia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Scandinavia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Singapore
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in South Africa
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in South Korea
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Spain
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Turkey
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The United Kingdom
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The United States
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading companies
Appendix
Methodology
About MarketLine

LIST OF TABLES

Table 1: Global pharmaceuticals market value: $ billion, 2012–16
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2016
Table 3: Global pharmaceuticals market share: % share, by value, 2016
Table 4: Global pharmaceuticals market value forecast: $ billion, 2016–21
Table 5: Asia-Pacific pharmaceuticals market value: $ billion, 2012–16
Table 6: Asia–Pacific pharmaceuticals market geography segmentation: $ billion, 2016
Table 7: Asia-Pacific pharmaceuticals market share: % share, by value, 2016
Table 8: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2016–21
Table 9: Europe pharmaceuticals market value: $ billion, 2012–16
Table 10: Europe pharmaceuticals market geography segmentation: $ billion, 2016
Table 11: Europe pharmaceuticals market share: % share, by value, 2016
Table 12: Europe pharmaceuticals market value forecast: $ billion, 2016–21
Table 13: France pharmaceuticals market value: $ billion, 2012–16
Table 14: France pharmaceuticals market geography segmentation: $ billion, 2016
Table 15: France pharmaceuticals market share: % share, by value, 2016
Table 16: France pharmaceuticals market value forecast: $ billion, 2016–21
Table 17: France size of population (million), 2012–16
Table 18: France gdp (constant 2005 prices, $ billion), 2012–16
Table 19: France gdp (current prices, $ billion), 2012–16
Table 20: France inflation, 2012–16
Table 21: France consumer price index (absolute), 2012–16
Table 22: France exchange rate, 2012–16
Table 23: Germany pharmaceuticals market value: $ billion, 2012–16
Table 24: Germany pharmaceuticals market geography segmentation: $ billion, 2016
Table 25: Germany pharmaceuticals market share: % share, by value, 2016
Table 26: Germany pharmaceuticals market value forecast: $ billion, 2016–21
Table 27: Germany size of population (million), 2012–16
Table 28: Germany gdp (constant 2005 prices, $ billion), 2012–16
Table 29: Germany gdp (current prices, $ billion), 2012–16
Table 30: Germany inflation, 2012–16
Table 31: Germany consumer price index (absolute), 2012–16
Table 32: Germany exchange rate, 2012–16
Table 33: Australia pharmaceuticals market value: $ billion, 2012–16
Table 34: Australia pharmaceuticals market geography segmentation: $ billion, 2016
Table 35: Australia pharmaceuticals market share: % share, by value, 2016
Table 36: Australia pharmaceuticals market value forecast: $ billion, 2016–21
Table 37: Australia size of population (million), 2012–16
Table 38: Australia gdp (constant 2005 prices, $ billion), 2012–16
Table 39: Australia gdp (current prices, $ billion), 2012–16
Table 40: Australia inflation, 2012–16
Table 41: Australia consumer price index (absolute), 2012–16
Table 42: Australia exchange rate, 2012–16
Table 43: Brazil pharmaceuticals market value: $ billion, 2012–16
Table 44: Brazil pharmaceuticals market geography segmentation: $ billion, 2016
Table 45: Brazil pharmaceuticals market share: % share, by value, 2016
Table 46: Brazil pharmaceuticals market value forecast: $ billion, 2016–21
Table 47: Brazil size of population (million), 2012–16
Table 48: Brazil gdp (constant 2005 prices, $ billion), 2012–16
Table 49: Brazil gdp (current prices, $ billion), 2012–16
Table 50: Brazil inflation, 2012–16
Table 51: Brazil consumer price index (absolute), 2012–16
Table 52: Brazil exchange rate, 2012–16
Table 53: Canada pharmaceuticals market value: $ billion, 2012–16
Table 54: Canada pharmaceuticals market geography segmentation: $ billion, 2016
Table 55: Canada pharmaceuticals market share: % share, by value, 2016
Table 56: Canada pharmaceuticals market value forecast: $ billion, 2016–21
Table 57: Canada size of population (million), 2012–16
Table 58: Canada gdp (constant 2005 prices, $ billion), 2012–16
Table 59: Canada gdp (current prices, $ billion), 2012–16
Table 60: Canada inflation, 2012–16
Table 61: Canada consumer price index (absolute), 2012–16
Table 62: Canada exchange rate, 2012–16
Table 63: China pharmaceuticals market value: $ billion, 2012–16
Table 64: China pharmaceuticals market geography segmentation: $ billion, 2016
Table 65: China pharmaceuticals market share: % share, by value, 2016
Table 66: China pharmaceuticals market value forecast: $ billion, 2016–21
Table 67: China size of population (million), 2012–16
Table 68: China gdp (constant 2005 prices, $ billion), 2012–16
Table 69: China gdp (current prices, $ billion), 2012–16
Table 70: China inflation, 2012–16
Table 71: China consumer price index (absolute), 2012–16
Table 72: China exchange rate, 2012–16
Table 73: India pharmaceuticals market value: $ billion, 2012–16
Table 74: India pharmaceuticals market geography segmentation: $ billion, 2016
Table 75: India pharmaceuticals market share: % share, by value, 2016
Table 76: India pharmaceuticals market value forecast: $ billion, 2016–21
Table 77: India size of population (million), 2012–16
Table 78: India gdp (constant 2005 prices, $ billion), 2012–16
Table 79: India gdp (current prices, $ billion), 2012–16
Table 80: India inflation, 2012–16
Table 81: India consumer price index (absolute), 2012–16
Table 82: India exchange rate, 2012–16
Table 83: Indonesia pharmaceuticals market value: $ billion, 2012–16
Table 84: Indonesia pharmaceuticals market geography segmentation: $ billion, 2016
Table 85: Indonesia pharmaceuticals market share: % share, by value, 2016
Table 86: Indonesia pharmaceuticals market value forecast: $ billion, 2016–21
Table 87: Indonesia size of population (million), 2012–16
Table 88: Indonesia gdp (constant 2005 prices, $ billion), 2012–16
Table 89: Indonesia gdp (current prices, $ billion), 2012–16
Table 90: Indonesia inflation, 2012–16
Table 91: Indonesia consumer price index (absolute), 2012–16
Table 92: Indonesia exchange rate, 2012–16
Table 93: Italy pharmaceuticals market value: $ billion, 2012–16
Table 94: Italy pharmaceuticals market geography segmentation: $ billion, 2016
Table 95: Italy pharmaceuticals market share: % share, by value, 2016
Table 96: Italy pharmaceuticals market value forecast: $ billion, 2016–21
Table 97: Italy size of population (million), 2012–16
Table 98: Italy gdp (constant 2005 prices, $ billion), 2012–16
Table 99: Italy gdp (current prices, $ billion), 2012–16
Table 100: Italy inflation, 2012–16
Table 101: Italy consumer price index (absolute), 2012–16
Table 102: Italy exchange rate, 2012–16
Table 103: Japan pharmaceuticals market value: $ billion, 2012–16
Table 104: Japan pharmaceuticals market geography segmentation: $ billion, 2016
Table 105: Japan pharmaceuticals market share: % share, by value, 2016
Table 106: Japan pharmaceuticals market value forecast: $ billion, 2016–21
Table 107: Japan size of population (million), 2012–16
Table 108: Japan gdp (constant 2005 prices, $ billion), 2012–16
Table 109: Japan gdp (current prices, $ billion), 2012–16
Table 110: Japan inflation, 2012–16
Table 111: Japan consumer price index (absolute), 2012–16
Table 112: Japan exchange rate, 2012–16
Table 113: Mexico pharmaceuticals market value: $ billion, 2012–16
Table 114: Mexico pharmaceuticals market geography segmentation: $ billion, 2016
Table 115: Mexico pharmaceuticals market share: % share, by value, 2016
Table 116: Mexico pharmaceuticals market value forecast: $ billion, 2016–21
Table 117: Mexico size of population (million), 2012–16
Table 118: Mexico gdp (constant 2005 prices, $ billion), 2012–16
Table 119: Mexico gdp (current prices, $ billion), 2012–16
Table 120: Mexico inflation, 2012–16
Table 121: Mexico consumer price index (absolute), 2012–16
Table 122: Mexico exchange rate, 2012–16
Table 123: Netherlands pharmaceuticals market value: $ billion, 2012–16
Table 124: Netherlands pharmaceuticals market geography segmentation: $ billion, 2016
Table 125: Netherlands pharmaceuticals market share: % share, by value, 2016
Table 126: Netherlands pharmaceuticals market value forecast: $ billion, 2016–21
Table 127: Netherlands size of population (million), 2012–16
Table 128: Netherlands gdp (constant 2005 prices, $ billion), 2012–16
Table 129: Netherlands gdp (current prices, $ billion), 2012–16
Table 130: Netherlands inflation, 2012–16
Table 131: Netherlands consumer price index (absolute), 2012–16
Table 132: Netherlands exchange rate, 2012–16
Table 133: North America pharmaceuticals market value: $ billion, 2012–16
Table 134: North America pharmaceuticals market geography segmentation: $ billion, 2016
Table 135: North America pharmaceuticals market share: % share, by value, 2016
Table 136: North America pharmaceuticals market value forecast: $ billion, 2016–21
Table 137: Russia pharmaceuticals market value: $ billion, 2012–16
Table 138: Russia pharmaceuticals market geography segmentation: $ billion, 2016
Table 139: Russia pharmaceuticals market share: % share, by value, 2016
Table 140: Russia pharmaceuticals market value forecast: $ billion, 2016–21
Table 141: Russia size of population (million), 2012–16
Table 142: Russia gdp (constant 2005 prices, $ billion), 2012–16
Table 143: Russia gdp (current prices, $ billion), 2012–16
Table 144: Russia inflation, 2012–16
Table 145: Russia consumer price index (absolute), 2012–16
Table 146: Russia exchange rate, 2012–16
Table 147: Scandinavia pharmaceuticals market value: $ billion, 2012–16
Table 148: Scandinavia pharmaceuticals market geography segmentation: $ billion, 2016
Table 149: Scandinavia pharmaceuticals market share: % share, by value, 2016
Table 150: Scandinavia pharmaceuticals market value forecast: $ billion, 2016–21
Table 151: Singapore pharmaceuticals market value: $ billion, 2012–16
Table 152: Singapore pharmaceuticals market geography segmentation: $ billion, 2016
Table 153: Singapore pharmaceuticals market share: % share, by value, 2016
Table 154: Singapore pharmaceuticals market value forecast: $ billion, 2016–21
Table 155: Singapore size of population (million), 2012–16
Table 156: Singapore gdp (constant 2005 prices, $ billion), 2012–16
Table 157: Singapore gdp (current prices, $ billion), 2012–16
Table 158: Singapore inflation, 2012–16
Table 159: Singapore consumer price index (absolute), 2012–16
Table 160: Singapore exchange rate, 2012–16
Table 161: South Africa pharmaceuticals market value: $ billion, 2012–16
Table 162: South Africa pharmaceuticals market geography segmentation: $ billion, 2016
Table 163: South Africa pharmaceuticals market share: % share, by value, 2016
Table 164: South Africa pharmaceuticals market value forecast: $ billion, 2016–21
Table 165: South Africa size of population (million), 2012–16
Table 166: South Africa gdp (constant 2005 prices, $ billion), 2012–16
Table 167: South Africa gdp (current prices, $ billion), 2012–16
Table 168: South Africa inflation, 2012–16
Table 169: South Africa consumer price index (absolute), 2012–16
Table 170: South Africa exchange rate, 2012–16
Table 171: South Korea pharmaceuticals market value: $ billion, 2012–16
Table 172: South Korea pharmaceuticals market geography segmentation: $ billion, 2016
Table 173: South Korea pharmaceuticals market share: % share, by value, 2016
Table 174: South Korea pharmaceuticals market value forecast: $ billion, 2016–21
Table 175: South Korea size of population (million), 2012–16
Table 176: South Korea gdp (constant 2005 prices, $ billion), 2012–16
Table 177: South Korea gdp (current prices, $ billion), 2012–16
Table 178: South Korea inflation, 2012–16
Table 179: South Korea consumer price index (absolute), 2012–16
Table 180: South Korea exchange rate, 2012–16
Table 181: Spain pharmaceuticals market value: $ billion, 2012–16
Table 182: Spain pharmaceuticals market geography segmentation: $ billion, 2016
Table 183: Spain pharmaceuticals market share: % share, by value, 2016
Table 184: Spain pharmaceuticals market value forecast: $ billion, 2016–21
Table 185: Spain size of population (million), 2012–16
Table 186: Spain gdp (constant 2005 prices, $ billion), 2012–16
Table 187: Spain gdp (current prices, $ billion), 2012–16
Table 188: Spain inflation, 2012–16
Table 189: Spain consumer price index (absolute), 2012–16
Table 190: Spain exchange rate, 2012–16
Table 191: Turkey pharmaceuticals market value: $ billion, 2012–16
Table 192: Turkey pharmaceuticals market geography segmentation: $ billion, 2016
Table 193: Turkey pharmaceuticals market share: % share, by value, 2016
Table 194: Turkey pharmaceuticals market value forecast: $ billion, 2016–21
Table 195: Turkey size of population (million), 2012–16
Table 196: Turkey gdp (constant 2005 prices, $ billion), 2012–16
Table 197: Turkey gdp (current prices, $ billion), 2012–16
Table 198: Turkey inflation, 2012–16
Table 199: Turkey consumer price index (absolute), 2012–16
Table 200: Turkey exchange rate, 2012–16
Table 201: United Kingdom pharmaceuticals market value: $ billion, 2012–16
Table 202: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2016
Table 203: United Kingdom pharmaceuticals market share: % share, by value, 2016
Table 204: United Kingdom pharmaceuticals market value forecast: $ billion, 2016–21
Table 205: United Kingdom size of population (million), 2012–16
Table 206: United Kingdom gdp (constant 2005 prices, $ billion), 2012–16
Table 207: United Kingdom gdp (current prices, $ billion), 2012–16
Table 208: United Kingdom inflation, 2012–16
Table 209: United Kingdom consumer price index (absolute), 2012–16
Table 210: United Kingdom exchange rate, 2012–16
Table 211: United States pharmaceuticals market value: $ billion, 2012–16
Table 212: United States pharmaceuticals market geography segmentation: $ billion, 2016
Table 213: United States pharmaceuticals market share: % share, by value, 2016
Table 214: United States pharmaceuticals market value forecast: $ billion, 2016–21
Table 215: United States size of population (million), 2012–16
Table 216: United States gdp (constant 2005 prices, $ billion), 2012–16
Table 217: United States gdp (current prices, $ billion), 2012–16
Table 218: United States inflation, 2012–16
Table 219: United States consumer price index (absolute), 2012–16
Table 220: United States exchange rate, 2012–15
Table 221: Bayer AG: key facts
Table 222: Bayer AG: key financials ($)
Table 223: Bayer AG: key financials (€)
Table 224: Bayer AG: key financial ratios
Table 225: Johnson & Johnson: key facts
Table 226: Johnson & Johnson: key financials ($)
Table 227: Johnson & Johnson: key financial ratios
Table 228: Novartis AG: key facts
Table 229: Novartis AG: key financials ($)
Table 230: Novartis AG: key financial ratios
Table 231: Pfizer Inc.: key facts
Table 232: Pfizer Inc.: key financials ($)
Table 233: Pfizer Inc.: key financial ratios
Table 234: Takeda Pharmaceutical Company Limited: key facts
Table 235: Takeda Pharmaceutical Company Limited: key financials ($)
Table 236: Takeda Pharmaceutical Company Limited: key financials (¥)
Table 237: Takeda Pharmaceutical Company Limited: key financial ratios
Table 238: Sanofi SA: key facts
Table 239: Sanofi SA: key financials ($)
Table 240: Sanofi SA: key financials (€)
Table 241: Sanofi SA: key financial ratios
Table 242: AstraZeneca PLC: key facts
Table 243: AstraZeneca PLC: key financials ($)
Table 244: AstraZeneca PLC: key financial ratios
Table 245: Laboratoires Pierre Fabre SA: key facts
Table 246: Les Laboratoires Servier: key facts
Table 247: Boehringer Ingelheim GmbH: key facts
Table 248: Boehringer Ingelheim GmbH: key financials ($)
Table 249: Boehringer Ingelheim GmbH: key financials (€)
Table 250: Boehringer Ingelheim GmbH: key financial ratios
Table 251: GlaxoSmithKline Plc: key facts
Table 252: GlaxoSmithKline Plc: key financials ($)
Table 253: GlaxoSmithKline Plc: key financials (£)
Table 254: GlaxoSmithKline Plc: key financial ratios
Table 255: Aché Laboratórios Farmacêuticos S.A.: key facts
Table 256: EMS SA: key facts
Table 257: Apotex, Inc.: key facts
Table 258: Merck & Co., Inc.: key facts
Table 259: Merck & Co., Inc.: key financials ($)
Table 260: Merck & Co., Inc.: key financial ratios
Table 261: Guangzhou Pharmaceutical Holdings Limited: key facts
Table 262: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 263: Shanghai Pharmaceuticals Holding Co Ltd: key financials ($)
Table 264: Shanghai Pharmaceuticals Holding Co Ltd: key financials (CNY)
Table 265: Shanghai Pharmaceuticals Holding Co Ltd: key financial ratios
Table 266: Yangtze River Pharmaceutical Group: key facts
Table 267: Yunnan Baiyao Group Co., Ltd.: key facts
Table 268: Yunnan Baiyao Group Co., Ltd.: key financials ($)
Table 269: Yunnan Baiyao Group Co., Ltd.: key financials (CNY)
Table 270: Yunnan Baiyao Group Co., Ltd.: key financial ratios
Table 271: Aurobindo Pharma Limited: key facts
Table 272: Aurobindo Pharma Limited: key financials ($)
Table 273: Aurobindo Pharma Limited: key financials (Rs.)
Table 274: Aurobindo Pharma Limited: key financial ratios
Table 275: Lupin Limited: key facts
Table 276: Lupin Limited: key financials ($)
Table 277: Lupin Limited: key financials (Rs.)
Table 278: Lupin Limited: key financial ratios
Table 279: Dr. Reddy's Laboratories Limited: key facts
Table 280: Dr. Reddy's Laboratories Limited: key financials ($)
Table 281: Dr. Reddy's Laboratories Limited: key financials (Rs.)
Table 282: Dr. Reddy's Laboratories Limited: key financial ratios
Table 283: Sun Pharmaceutical Industries Ltd.: key facts
Table 284: Sun Pharmaceutical Industries Ltd.: key financials ($)
Table 285: Sun Pharmaceutical Industries Ltd.: key financials (Rs.)
Table 286: Sun Pharmaceutical Industries Ltd.: key financial ratios
Table 287: PT Kalbe Farma Tbk: key facts
Table 288: PT Kalbe Farma Tbk: key financials ($)
Table 289: PT Kalbe Farma Tbk: key financials (IDR)
Table 290: PT Kalbe Farma Tbk: key financial ratios
Table 291: Chiesi Farmaceutici S.p.A.: key facts
Table 292: The Menarini Group: key facts
Table 293: Recordati S.p.A.: key facts
Table 294: Daiichi Sankyo Co., Ltd.: key facts
Table 295: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 296: Daiichi Sankyo Co., Ltd.: key financials (¥)
Table 297: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 298: Mitsubishi Tanabe Pharma Corporation: key facts
Table 299: Mitsubishi Tanabe Pharma Corporation: key financials ($)
Table 300: Mitsubishi Tanabe Pharma Corporation: key financials (¥)
Table 301: Mitsubishi Tanabe Pharma Corporation: key financial ratios
Table 302: F. Hoffmann-La Roche Ltd: key facts
Table 303: F. Hoffmann-La Roche Ltd: key financials ($)
Table 304: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 305: F. Hoffmann-La Roche Ltd: key financial ratios
Table 306: Astellas Pharma Inc.: key facts
Table 307: Astellas Pharma Inc.: key financials ($)
Table 308: Astellas Pharma Inc.: key financials (¥)
Table 309: Astellas Pharma Inc.: key financial ratios
Table 310: Adcock Ingram Holdings Limited: key facts
Table 311: Adcock Ingram Holdings Limited: key financials ($)
Table 312: Adcock Ingram Holdings Limited: key financials (ZAR)
Table 313: Adcock Ingram Holdings Limited: key financial ratios
Table 314: Aspen Pharmacare Holdings Ltd: key facts
Table 315: Aspen Pharmacare Holdings Ltd: key financials ($)
Table 316: Aspen Pharmacare Holdings Ltd: key financials (ZAR)
Table 317: Aspen Pharmacare Holdings Ltd: key financial ratios
Table 318: CKD Bio Corporation: key facts
Table 319: Daewoong Pharmaceutical Co., Ltd.: key facts
Table 320: Daewoong Pharmaceutical Co., Ltd.: key financials ($)
Table 321: Daewoong Pharmaceutical Co., Ltd.: key financials (KRW)
Table 322: Daewoong Pharmaceutical Co., Ltd.: key financial ratios
Table 323: Hanmi Science Co., Ltd.: key facts
Table 324: Hanmi Science Co., Ltd.: key financials ($)
Table 325: Hanmi Science Co., Ltd.: key financials (KRW)
Table 326: Hanmi Science Co., Ltd.: key financial ratios
Table 327: Almirall S.A.: key facts
Table 328: Almirall S.A.: key financials ($)
Table 329: Almirall S.A.: key financials (€)
Table 330: Almirall S.A.: key financial ratios
Table 331: Abdi İbrahim: key facts

LIST OF FIGURES

Figure 1: Global pharmaceuticals market value: $ billion, 2012–16
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 3: Global pharmaceuticals market share: % share, by value, 2016
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2016–21
Figure 5: Forces driving competition in the global pharmaceuticals market, 2016
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2016
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2016
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2016
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2016
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2016
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2012–16
Figure 12: Asia–Pacific pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2016
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2016–21
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2016
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2016
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2016
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2016
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2016
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2016
Figure 21: Europe pharmaceuticals market value: $ billion, 2012–16
Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 23: Europe pharmaceuticals market share: % share, by value, 2016
Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2016–21
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2016
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2016
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2016
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2016
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2016
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2016
Figure 31: France pharmaceuticals market value: $ billion, 2012–16
Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 33: France pharmaceuticals market share: % share, by value, 2016
Figure 34: France pharmaceuticals market value forecast: $ billion, 2016–21
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2016
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2016
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2016
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2016
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2016
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2016
Figure 41: Germany pharmaceuticals market value: $ billion, 2012–16
Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 43: Germany pharmaceuticals market share: % share, by value, 2016
Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2016–21
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2016
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2016
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2016
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2016
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2016
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2016
Figure 51: Australia pharmaceuticals market value: $ billion, 2012–16
Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 53: Australia pharmaceuticals market share: % share, by value, 2016
Figure 54: Australia pharmaceuticals market value forecast: $ billion, 2016–21
Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2016
Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2016
Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2016
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2016
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2016
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2016
Figure 61: Brazil pharmaceuticals market value: $ billion, 2012–16
Figure 62: Brazil pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 63: Brazil pharmaceuticals market share: % share, by value, 2016
Figure 64: Brazil pharmaceuticals market value forecast: $ billion, 2016–21
Figure 65: Forces driving competition in the pharmaceuticals market in Brazil, 2016
Figure 66: Drivers of buyer power in the pharmaceuticals market in Brazil, 2016
Figure 67: Drivers of supplier power in the pharmaceuticals market in Brazil, 2016
Figure 68: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2016
Figure 69: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2016
Figure 70: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2016
Figure 71: Canada pharmaceuticals market value: $ billion, 2012–16
Figure 72: Canada pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 73: Canada pharmaceuticals market share: % share, by value, 2016
Figure 74: Canada pharmaceuticals market value forecast: $ billion, 2016–21
Figure 75: Forces driving competition in the pharmaceuticals market in Canada, 2016
Figure 76: Drivers of buyer power in the pharmaceuticals market in Canada, 2016
Figure 77: Drivers of supplier power in the pharmaceuticals market in Canada, 2016
Figure 78: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2016
Figure 79: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2016
Figure 80: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2016
Figure 81: China pharmaceuticals market value: $ billion, 2012–16
Figure 82: China pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 83: China pharmaceuticals market share: % share, by value, 2016
Figure 84: China pharmaceuticals market value forecast: $ billion, 2016–21
Figure 85: Forces driving competition in the pharmaceuticals market in China, 2016
Figure 86: Drivers of buyer power in the pharmaceuticals market in China, 2016
Figure 87: Drivers of supplier power in the pharmaceuticals market in China, 2016
Figure 88: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2016
Figure 89: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2016
Figure 90: Drivers of degree of rivalry in the pharmaceuticals market in China, 2016
Figure 91: India pharmaceuticals market value: $ billion, 2012–16
Figure 92: India pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 93: India pharmaceuticals market share: % share, by value, 2016
Figure 94: India pharmaceuticals market value forecast: $ billion, 2016–21
Figure 95: Forces driving competition in the pharmaceuticals market in India, 2016
Figure 96: Drivers of buyer power in the pharmaceuticals market in India, 2016
Figure 97: Drivers of supplier power in the pharmaceuticals market in India, 2016
Figure 98: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2016
Figure 99: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2016
Figure 100: Drivers of degree of rivalry in the pharmaceuticals market in India, 2016
Figure 101: Indonesia pharmaceuticals m
Skip to top


Ask Your Question

Pharmaceuticals Global Industry Almanac 2017
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: